COVID-19

News

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it cu

News

AZ joins COVID-19 vaccine race with Oxford Uni partnership

AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July.

News

Shares in Vertex jump on overnight success of CF triple ther...

Shares in US pharma Vertex were up sharply in premarket trading after its newly-launched cystic fibrosis triple therapy attained blockbuster status almost overnight, leading

Views & Analysis

How AI is fighting COVID-19: the companies using intelligent...

The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.

News

Gilead's remdesivir hailed as COVID-19 standard of care afte...

It's official - Gilead's remdesivir helps severely ill patients recover faster from COVID-19, according to results from a phase 3 placebo-controlled trial.

Partner Content